Kyungdong Pharm
KOSDAQ:011040
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kyungdong Pharm
KOSDAQ:011040
|
KR |
|
Poly Developments and Holdings Group Co Ltd
SSE:600048
|
CN |
|
J
|
J Sainsbury PLC
OTC:JSAIY
|
UK |
|
D
|
Dream Us Co
KOSDAQ:060570
|
KR |
|
K
|
Kimball International Inc
F:KB1B
|
US |
|
R
|
Rigolleau SA
BCBA:RIGO
|
AR |
|
E
|
Eco World International Bhd
KLSE:EWINT
|
MY |
|
F
|
Fore Kopi Indonesia PT Tbk
IDX:FORE
|
ID |
|
M
|
ME Renewable Power Corp
OTC:MEPW
|
LV |
|
Multistrada Arah Sarana Tbk PT
IDX:MASA
|
ID |
|
FJ Next Holdings Co Ltd
TSE:8935
|
JP |
|
Allos SA
BOVESPA:ALOS3
|
BR |
Bankruptcy Probability
Kyungdong Pharm's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Kyungdong Pharm Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
K
|
Kyungdong Pharm
KOSDAQ:011040
|
164.3B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Kyungdong Pharm's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Kyungdong Pharm has total debt of 30.5B KRW. This includes both short-term (30.4B KRW) and long-term (37.9m KRW) debt.
You can find a full breakdown on its Balance Sheet.
